Search

everythinglearnresearchcommunity

for

Search:↓

Combining fractional CO2 laser with topical dutasteride is more effective for treating male hair loss than using the laser alone.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Gabapentin helps with scalp itch, dutasteride works for frontal fibrosing alopecia, and more research is needed for better PCA treatments.

Retinoic acid is effective for treating eruptive vellus hair cysts.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Topical calcipotriol may help treat alopecia areata, especially in those with low vitamin D.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated.

Azelaic acid and anthralin are similarly effective for treating patchy hair loss.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Azelaic acid treats acne, rosacea, and hyperpigmentation with minimal side effects.

Intralesional triamcinolone is more effective than topical betamethasone for treating localized alopecia areata.

Clascoterone 1% cream is a promising new treatment for acne.

Isotretinoin therapy for acne can cause many reversible side effects, mainly mild skin conditions, and patient understanding of these effects can improve treatment adherence.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

A new treatment plan helps manage folliculitis decalvans effectively.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Apremilast did not work for treating severe alopecia areata.

The Exfoliate-Dissolve-Repair skincare approach may effectively treat keratosis pilaris and reduce the need for corticosteroids.

Topical tacrolimus can effectively treat erosive pustular dermatosis and related hair loss.

The liposomal hydrogel shows promise for hair loss treatment but needs more testing.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.